Pacira Pharmaceuticals reported earnings of $0.24 per share beat views
Pacira Pharmaceuticals (NASDAQ:PCRX) reported Q2 2018 earnings, coming in at $0.24 per share, beating Wall Street’s estimates of $0.05 per Share. Revenue for the quarter came in at $84.10 million beating analyst estimates of $77.53 million.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.